Trials / Completed
CompletedNCT03761797
A Long-term Study on the Side Effects of TRADIANCE in Japanese Patients With Type 2 Diabetes
Post Marketing Surveillance in Japan on Long Term Drug Use of TRADIANCE® Combination Tablets AP and BP in Patients With Type 2 Diabetes Mellitus
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 1,164 (actual)
- Sponsor
- Boehringer Ingelheim · Industry
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
Study objectives is to investigate the safety of long-term daily use of TRADIANCE® Combination Tablets AP and BP in Japanese patients with Type 2 Diabetes mellitus (T2DM) used in routine care.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | TRADIANCE® Combination Tablets AP | Fixed dose combination |
| DRUG | TRADIANCE® Combination Tablets BP | Fixed dose combination |
Timeline
- Start date
- 2019-01-15
- Primary completion
- 2021-03-10
- Completion
- 2021-04-27
- First posted
- 2018-12-03
- Last updated
- 2023-01-23
- Results posted
- 2023-01-23
Locations
1 site across 1 country: Japan
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT03761797. Inclusion in this directory is not an endorsement.